Final results of the PETACC-1 trial of bolus 5-FU/LV vs raltitrexed: An unsuccessful story?

Final results of the PETACC-1 trial of bolus 5-FU/LV vs raltitrexed: An unsuccessful story?

Bibliographic Details
Main Authors:	Popov, I, Wils, J, Carrato, A, Sobrero, A, Vincent, M, Kerr, D, Labianca, R, Pignatti, F, Praet, M, Nordlinger, B
Format:	Journal article
Published:	2008

Similar Items

Raltitrexed (Tomudex) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1).
by: Popov, I, et al.
Published: (2008)

Raltitrexed increases radiation sensitivity of esophageal squamous carcinoma cells
by: Wen-Xiu Ding, et al.
Published: (2019-02-01)

Phase I study of GW572016 (lapatinib), a dual kinase inhibitor, in combination with irinotecan (IR), 5-fluorouracil (FU) and leucovorin (LV).
by: Midgley, R, et al.
Published: (2005)

Formulation of Folate-Modified Raltitrexed-Loaded Nanoparticles for Colorectal Cancer Theranostics
by: Justin G. Rosch, et al.
Published: (2020-02-01)

A case of pathological complete response with liposomal irinotecan + 5-FU/LV for unresectable locally advanced pancreatic cancer
by: Koji Kikuchi, et al.
Published: (2022-10-01)

Raltitrexed regulates proliferation and apoptosis of HGC-27 cells by upregulating RSK4
by: Cong Hu, et al.
Published: (2022-08-01)

Safety of capecitabine (X) compared to fluorouracil/leucovorin (5-FU/LV) for the adjuvant treatment of elderly colon cancer patients (pts).
by: Diaz-Rubio, E, et al.
Published: (2004)

Preliminary outcomes of DEB-TACE loaded with raltitrexed in the treatment of unresectable or recurrent hepatocellular carcinoma
by: Yonghua Bi, et al.
Published: (2023-02-01)

Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial.
by: Cassidy, J, et al.
Published: (2006)

Efficacy and tolerance of LV5FU2-carboplatin chemotherapy in patients with advanced pancreatic ductal adenocarcinoma after failure of standard regimens
by: Thomas Chaigneau, et al.
Published: (2023-03-01)

A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases
by: Bigam David, et al.
Published: (2009-05-01)

Real-World Results of Raltitrexed Combined with S-1 and Bevacizumab in Heavily Pretreated Metastatic Colorectal Cancer
by: Liu X, et al.
Published: (2023-03-01)

Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
by: Lisi Zeng, et al.
Published: (2021-08-01)

The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation
by: D Hind, et al.
Published: (2008-05-01)

Efficacy And Safety Of Raltitrexed Plus Oxaliplatin-Based Transarterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma
by: Shao W, et al.
Published: (2019-11-01)

Workbook of an unsuccessful architect /
by: 221466 Stone, Harris
Published: (1973)

Unsuccessful pedagogical situations
by: Victoria V. Dobrova
Published: (2023-08-01)

Interstitial lung disease induced by raltitrexed-oxaliplatin based chemotherapy for colorectal cancer: a case report
by: Montserrat Carreres-Prieto, et al.
Published: (2015-01-01)

Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis
by: Hongchao Zhen, et al.
Published: (2023-03-01)

Smulkmena LV
by: Zigmas Zinkevičius
Published: (2011-12-01)

The LV-hyperstructures
by: N. Lygeros, et al.
Published: (2013-12-01)

Understanding the need of LV pressure for the estimation of LV diastolic functions
by: Xi, J, et al.
Published: (2012)

Pharmacoeconomic analysis of Capecitabine in the adjuvant setting. Results from the X-ACT trial comparing capecitabine with 5-FU/LV in patients with Dukes' C colon cancer
by: Douillard, J, et al.
Published: (2004)

Simultaneous quantification method for 5-FU, uracil, and tegafur using UPLC-MS/MS and clinical application in monitoring UFT/LV combination therapy after hepatectomy
by: Ken Shiraiwa, et al.
Published: (2021-02-01)

Acute exudative polymorphous vitelliform maculopathy: To bolus or not to bolus?
by: Pier Luigi Grenga, et al.
Published: (2018-01-01)

Clinical Outcomes of Drug-Eluting Bead Transarterial Chemoembolization Loaded with Raltitrexed for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma
by: Yonghua Bi, et al.
Published: (2022-01-01)

Apatinib plus hepatic arterial infusion of oxaliplatin and raltitrexed for hepatocellular carcinoma with extrahepatic metastasis: phase II trial
by: Shiguang Chen, et al.
Published: (2024-10-01)

Preliminary outcomes of raltitrexed eluting bead-transarterial chemoembolization using Callispheres® beads for gastrointestinal adenocarcinoma liver metastasis
by: Yonghua Bi, et al.
Published: (2022-07-01)

The Knowability Paradox and Unsuccessful Updates
by: Wójcik Arkadiusz
Published: (2020-06-01)

Comparison of Absorbed Dose in Plasticine Bolus and Silicone Rubber Bolus
by: Leony Chantika Leony, et al.
Published: (2022-03-01)

L.V. Khristoforov
by: article Editorial
Published: (2019-02-01)

Biweekly Raltitrexed Combined With Irinotecan as Second-Line Therapy for Patients With Metastatic Colorectal Cancer: A Phase II Trial
by: Ke Cheng MD, PhD, et al.
Published: (2022-02-01)

Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy
by: Vadiaka Maria, et al.
Published: (2002-01-01)

A set of Non-Synthetic test systems of European LV Rural, LV urban and hybrid MV/LV industrial distribution networks
by: Tarikua Taye, et al.
Published: (2024-07-01)

A Story of One Unsuccessful “Island” Kaliningrad 1991- 2010: from “Baltic Hong Kong” to the Center dependent entity
by: Sergey Sukhankin
Published: (2014-12-01)

Unsuccessful transscleral cyclophotocoagulation in oculocutaneous albinism
by: Aaron D. Dotson, et al.
Published: (2024-06-01)

Unsuccessful treatment of sideroblastic anaemia with chloroquine
by: Lima Carmen S. P., et al.
Published: (2003-01-01)

Efficacy, tolerability and management of raltitrexed (Tomudex) monotherapy in patients with advanced colorectal cancer. a review of phase II/III trials.
by: Cunningham, D, et al.
Published: (2002)

A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.
by: Lloyd Jones, et al.
Published: (2001-01-01)

Metastatic colorectal cancer: irinotecan plus infusional, bolus or oral fluoropyrimidines as first-line treatment.
by: Kerr, D
Published: (2008)